Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any nephrotic syndrome in which the cause of the disease is a mutation in the PTPRO gene.
Features include always present findings: Nephrotic syndrome, Edema, Hypoalbuminemia, and Protein in the urine (proteinuria); and common findings: Tubulointerstitial fibrosis, Focal segmental glomerulosclerosis, and Minimal change glomerulonephritis. 8 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Kidneys and urinary system | 6 | Stage 5 chronic kidney disease, Nephrotic syndrome, Tubulointerstitial fibrosis |
PTPRO function has not been fully characterized.
Nephrotic syndrome, type 6 is associated with mutations in the PTPRO gene on chromosome 12.
Genetic testing for PTPRO is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 4 always present features, 3 common features.
No clinical trials have been registered for nephrotic syndrome, type 6.
69 publications have been identified in PubMed for nephrotic syndrome, type 6. Research spans Case Report / Case Series (38%), Clinical Trial Publication (19%), and Basic Science / Preclinical (17%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 26 | 38% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 12:50 AM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
13 |
19% |
Laboratory research | 12 | 17% |
Disease patterns and progression | 10 | 14% |
Research summaries | 8 | 12% |
Bhaumik A (2026). [PMID: 42078290](https://pubmed.ncbi.nlm.nih.gov/42078290/). *Cureus*. [Epidemiology / Natural History]
Henriques AR (2026). [PMID: 41852509](https://pubmed.ncbi.nlm.nih.gov/41852509/). *Front Nephrol*. [Case Report / Case Series]
Oatley Z (2026). [PMID: 41906863](https://pubmed.ncbi.nlm.nih.gov/41906863/). *Cell Transplant*. [Review / Meta-Analysis]
Li H (2026). [PMID: 40388905](https://pubmed.ncbi.nlm.nih.gov/40388905/). *American journal of nephrology*. [Clinical Trial Publication]
Chen HR (2026). [PMID: 41948115](https://pubmed.ncbi.nlm.nih.gov/41948115/). *Clin Kidney J*. [Clinical Trial Publication]
Wani MA (2026). [PMID: 41884230](https://pubmed.ncbi.nlm.nih.gov/41884230/). *World J Nephrol*. [Case Report / Case Series]
Madhuri PS (2026). [PMID: 41838286](https://pubmed.ncbi.nlm.nih.gov/41838286/). *CEN Case Rep*. [Case Report / Case Series]
Angioi A (2026). [PMID: 41898697](https://pubmed.ncbi.nlm.nih.gov/41898697/). *Int J Mol Sci*. [Case Report / Case Series]
Atay İ (2026). [PMID: 41852044](https://pubmed.ncbi.nlm.nih.gov/41852044/). *Acta Clin Belg*. [Review / Meta-Analysis]
Wang L (2026). [PMID: 41509998](https://pubmed.ncbi.nlm.nih.gov/41509998/). *Kidney medicine*. [Clinical Trial Publication]